Consultation record
Submissions accepted — page 3
The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.
Submissions
681 documents · page 3 of 23
Table 1. Submissions with this disposition, on this page.
| Reference | Consultation | Respondent | Point raised |
|---|---|---|---|
| DRAFT-CITATION-POL/008 | Draft citation policy | Dr Oswin Yorkstone | The position of a contributor who withdraws consent is not stated |
| DRAFT-CITATION-POL/007 | Draft citation policy | Dr Kamila Ubertini | Whether external reviewers are paid is not stated |
| DRAFT-CITATION-POL/005 | Draft citation policy | Dr Vasilisa Immelmann | The policy does not say what happens to a document the Institute is asked to remove |
| DRAFT-CITATION-POL/002 | Draft citation policy | Dr Delphine Trelawney | The search date is not on the face of the document |
| DRAFT-PROGRAMME-RE/013 | Draft policy: labelling of Institute-constructed programme records | Dr Melisande Thorsby-Nakamura | The position of a contributor who withdraws consent is not stated |
| DRAFT-PROGRAMME-RE/009 | Draft policy: labelling of Institute-constructed programme records | Dr Beatrijs Hazelrigg | The same concept is given three different names in one document |
| DRAFT-PROGRAMME-RE/007 | Draft policy: labelling of Institute-constructed programme records | Dr Yolanda Norrington-Bhatt | The terms on which the documents may be reused are not stated |
| DRAFT-ENDOTOXIN-ST/001 | Draft standard: bacterial endotoxin testing of peptide presentations | Dr Oisín Marchetti-Bassey | A determination does not record the version of the standard it was made under |
| DRAFT-ENDOTOXIN-ST/004 | Draft standard: bacterial endotoxin testing of peptide presentations | Dr Hyacinth Oyelaran-Steen | Terms are used in senses that differ from established pharmacopoeial usage |
| DRAFT-ENDOTOXIN-ST/010 | Draft standard: bacterial endotoxin testing of peptide presentations | Kolawole Jankowiak-Osei | The scope does not say which materials the standard excludes |
| DRAFT-ENDOTOXIN-ST/002 | Draft standard: bacterial endotoxin testing of peptide presentations | Dr Rurik Haverkamp-Diallo | Quantitative claims are reproduced without the method that produced them |
| DRAFT-ENDOTOXIN-ST/003 | Draft standard: bacterial endotoxin testing of peptide presentations | Dr Amara Vandergraaf | The limitations section states what the method cannot do but not what a reader will wrongly conclude |
| DRAFT-ENDOTOXIN-ST/007 | Draft standard: bacterial endotoxin testing of peptide presentations | Dr Rosalind Grünbaum-Sowande | The standard does not say what to do with a result outside the expected range |
| DRAFT-ANALYTICAL-S/005 | Draft scope of the analytical and methodological standards series | Dr Jacinta Steenkamp-Ferreira | The same concept is given three different names in one document |
| DRAFT-ANALYTICAL-S/002 | Draft scope of the analytical and methodological standards series | Yusuf Whitmarsh-Obi | A withdrawn document should not simply disappear |
| DRAFT-ANALYTICAL-S/007 | Draft scope of the analytical and methodological standards series | Dr Lorcan Zaleski-Mbeki | The same quantity is presented differently in two series |
| DRAFT-ANALYTICAL-S/003 | Draft scope of the analytical and methodological standards series | Dr Wolfram Kaltenbach-Mensah | The search date is not on the face of the document |
| DRAFT-ANALYTICAL-S/004 | Draft scope of the analytical and methodological standards series | Quentin Gwynne-Sarpong | A printed copy loses the information that makes it checkable |
| DRAFT-GLP1-OBESITY/012 | Draft synthesis: glucagon-like peptide-1 receptor agonists for weight… | Dr Katarzyna Oppenheimer-Ade | A single-trial result is presented in the visual form of a pooled estimate |
| DRAFT-GLP1-OBESITY/013 | Draft synthesis: glucagon-like peptide-1 receptor agonists for weight… | Dr Bertrand Steenkamp-Ferreira | Doses differing several-fold are pooled without examining dose-response |
| DRAFT-GLP1-OBESITY/009 | Draft synthesis: glucagon-like peptide-1 receptor agonists for weight… | Kolawole Oppenheimer-Ade | Risk-of-bias judgements are reported as an overall rating without the domains |
| DRAFT-GLP1-OBESITY/015 | Draft synthesis: glucagon-like peptide-1 receptor agonists for weight… | Dr Torvald Kettlewell | The conclusion is stated more strongly than the certainty rating supports |
| DRAFT-GLP1-OBESITY/010 | Draft synthesis: glucagon-like peptide-1 receptor agonists for weight… | Dr Jozef Brandvold-Achterberg | Registered trials that never reported are not counted anywhere in the review |
| DRAFT-LEAN-MASS-SC/007 | Draft scoping review: change in lean mass during pharmacologically… | Dr Georgiana Mountstephen | Results at materially different follow-up durations are pooled |
| DRAFT-LEAN-MASS-SC/003 | Draft scoping review: change in lean mass during pharmacologically… | Dr Liesbeth Quenneville | The review does not say when it will be updated or what would trigger an update |
| DRAFT-LEAN-MASS-SC/001 | Draft scoping review: change in lean mass during pharmacologically… | Dr Zebedee Zaleski-Mbeki | Analytical surveys are treated as evidence about suppliers when they establish only what was in a… |
| DRAFT-LEAN-MASS-SC/006 | Draft scoping review: change in lean mass during pharmacologically… | Dr Ludmila Tollemache | Absence of evidence is presented in a form a reader will take as negative evidence |
| DRAFT-GASTROPARESI/005 | Draft safety review: delayed gastric emptying and procedural sedation | Dr Gervase Abergavenny | The search strategy as published cannot be re-run |
| DRAFT-GASTROPARESI/009 | Draft safety review: delayed gastric emptying and procedural sedation | Dr Yolanda Norrington-Bhatt | Doses differing several-fold are pooled without examining dose-response |
| DRAFT-GASTROPARESI/012 | Draft safety review: delayed gastric emptying and procedural sedation | Dr Ivo Quintanilha | The search date is not on the face of the document |
page 3 of 23